How Rules-Based Artificial Intelligence in Healthcare is Reshaping Pharmacy Surveillance
Written by
Inovalon
Quick Navigation
Artificial intelligence (AI) is revolutionizing healthcare, with more than 80% of health system executives expecting AI to significantly impact their organizations in 2025. Nowhere is this transformation more critical than in pharmacy surveillance, where rules-based AI’s ability to identify complex drug interactions, provide real-time insights, and enhance patient safety is setting new standards of excellence.
As medication regimens grow increasingly complex, AI offers something traditional systems cannot: the power to analyze thousands of data points simultaneously, detecting potential adverse events before they reach the patient. For healthcare leaders seeking to reduce medication errors, improve outcomes, and control costs, AI-powered pharmacy surveillance has become indispensable.
Artificial intelligence in healthcare: beyond the buzz
Artificial intelligence in healthcare uses advanced algorithms to analyze patient data, identify patterns, and support clinical decision-making. While AI applications span from diagnostics to treatment planning, one of the most immediate impacts is in pharmacy surveillance – where preventing medication errors can significantly improve outcomes and reduce costs.
Where manual pharmacy surveillance falls short
Traditional pharmacy surveillance relies on pharmacists manually reviewing charts and medication orders – a time-consuming process prone to delays and oversight. With thousands of national drug codes listed by the U.S. Food and Drug Administration, healthcare providers face an overwhelming challenge in assessing medication risks.
Accounting for one-third of all inpatient adverse events, about 1 million emergency department visits, and over 3.5 million physician office visits each year, adverse drug events are both dangerous and costly.
A rules-based AI-powered solution
Inovalon’s VigiLanz Pharmacy Surveillance, an eight-time Best in KLAS winner, transforms manual approaches with rules-based AI that monitors patient data in near real-time, automatically alerting pharmacists to potential issues before harm occurs.
The solution provides:
- Customizable rules that reduce manual chart reviews
- Near real-time alerts enabling timely interventions
- Seamless EHR integration within existing workflows
- User-friendly interfaces configurable to pharmacists’ needs
Real-world results
Adventist Health and Rideout, a nonprofit community-based health system in California, achieved remarkable results using VigiLanz Pharmacy Surveillance:
- $500,000 annual reduction in antibiotic expenses
- Significant reduction in C. diff infections
- More proactive interventions and better clinical outcomes
As Bryce Whitesides, Pharm.D. at Adventist Health notes, “Clinical surveillance is a very powerful tool that we’ve used to make very significant interventions, not only in our patients’ lives but the hospital at large.”
Freeman Health System, a 485-bed, three-hospital system in Joplin, Missouri, similarly implemented the AI-based technology to:
- Generate $2.9 million in estimated quarterly cost savings through pharmacy interventions
- Reduce 30-day readmission rates from 21.25% to just 5.25% for patients receiving pharmacy education
- Implement 650 custom rules to improve medication safety
The path to successful AI integration
As provider organizations consider implementing AI healthcare solutions, common questions about security, reliability, and effectiveness naturally arise. Healthcare analytics systems should address these concerns through robust data protection protocols that meet healthcare compliance standards while combining rules-based AI capabilities with human expertise – flagging potential issues for pharmacist review rather than making autonomous decisions.
Most modern pharmacy surveillance solutions can be implemented within 60-90 days with minimal disruption to existing workflows, allowing healthcare organizations to quickly realize returns on their investment while maintaining operational continuity.
Looking ahead, the potential for rules-based AI in pharmacy surveillance continues to expand. Research from the University of Maryland, New Jersey Institute of Technology, and Inovalon demonstrates the effectiveness of AI models that consider patient history along with the sequence and timing of medical events to predict adverse drug events. These sophisticated models analyze thousands of factors simultaneously, revealing previously unknown risk factors and helping pharmacists intervene at precisely the right moment.
Transform your pharmacy surveillance practices
Complex goals don’t need complex solutions. VigiLanz Pharmacy Surveillance empowers pharmacy teams to protect patients by identifying the right intervention for the right patient at the right time.
Be the hero your hospital needs. Talk to an expert today to discover how rules-based AI-powered pharmacy surveillance can transform medication safety at your organization.
Inovalon and design® and Inovalon® are trademarks of Inovalon, Inc.
